0000947871-23-001120.txt : 20231204 0000947871-23-001120.hdr.sgml : 20231204 20231204150726 ACCESSION NUMBER: 0000947871-23-001120 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 EFFECTIVENESS DATE: 20231204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Graviton BioScience Corp CENTRAL INDEX KEY: 0001847048 IRS NUMBER: 851662151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498756 FILM NUMBER: 231462573 BUSINESS ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 332-400-0444 MAIL ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001847048 Graviton BioScience Corp 125 WEST END AVE. SUITE 301 NEW YORK NY NEW YORK 10023 1-332-400-0444 DELAWARE None None Corporation true 2020 Samuel D. Waksal 125 WEST END AVE. SUITE 301 New York NY NEW YORK 10023 Executive Officer Director Bihua Chen 200 Clarendon St., 52nd Floor Boston MA MASSACHUSETTS 02116 Director Stelios Papadopoulos 125 WEST END AVE. SUITE 301 New York NY NEW YORK 10023 Director David MacMillan 260 Gallup Rd. Princeton NJ NEW JERSEY 08540 Director Jeremy Levin 441 9th Ave. 14th Floor New York NY NEW YORK 10001 Director Ran Nussbaum 14 Shenkar St. Herzliya L3 ISRAEL 4672514 Director James Boylan 106th W. 56th. St. 8th Floor New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06b false 2023-11-22 false true false 0 24999998 24999998 0 false 1 0 0 0 false Graviton BioScience Corp /s/ Samuel D. Waksal Samuel D. Waksal Chief Executive Officer 2023-12-03